News
8h
ABS-CBN on MSNUS approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Discover the 8 essential travel vaccines for 2025. Learn which immunizations you need for different destinations and how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results